Evidence map›Paper›PMID 41078081›Full record

ArticleESC heart failure2025

Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo-HF study.

Jorge Campos, Pau Llàcer, François Croset, Marina García, Carlos Pérez, Alberto Pérez, Marina Vergara, Paul Cevallos, Martín Fabregate, Cristina Fernández and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in ESC heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07597512 (Association of Urinary Chloride and Sodium Dynamics With Multiparametrically Assessed Residual Congestion in Acute Heart Failure), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07597512 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Association of Urinary Chloride and Sodium Dynamics With Multiparametrically Assessed Residual Congestion in Acute Heart Failure (CLORINA-IC)

TypeobservationalSponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalRan2026 to 2028Enrolled223ConditionsAcute Heart Failure (AHF), Heart Failure, Congestion
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jorge CamposInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Pau LlàcerInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.ORCID https://orcid.org/0000-0002-0988-0599
François CrosetInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Marina GarcíaInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Carlos PérezInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Alberto PérezInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Marina VergaraInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Paul CevallosInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Martín FabregateInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Cristina FernándezInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Raúl RuizInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Daniel UserosInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Miriam MenachoClinical Biochemistry Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Miriam DomínguezNephrology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Esteban PérezInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Julio NúñezCardiology Department, Hospital Clínico Universitario, Universitat de València, INCLIVA, Valencia, Spain.
Luis ManzanoInternal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIn acute heart failure (AHF), precise assessment of congestion is critical to guide therapy. Urinary sodium (uNa) and urinary chloride (uCl) have emerged as potential biomarkers to monitor decongestion, but their comparative trajectories and links to residual congestion remain unclear. This study examined urinary uCl and uNa trajectories during AHF hospitalization in elderly patients with preserved ejection fraction (HFpEF) and their association with fluid overload. METHODS AND

resultsThis prospective, single-centre study enrolled 70 patients hospitalized for AHF with HFpEF. All received intravenous furosemide for ≥72 h. Serial measurements of uNa, uCl, clinical congestion score (CCS), portal vein pulsatility and estimated plasma volume status (ePVS) were performed. Linear mixed-effects models analysed electrolyte trajectories in relation to residual congestion (CCS ≥ 2, portal vein pulsatility ≥ 30% and ePVS > 5.5 mL/g). The median age was 88 years (IQR: 85-91), and 72.8% were women. Baseline median uCl and uNa were 94 mmol/L (IQR: 68-116) and 81 mmol/L (IQR: 58-97), respectively. uCl declined significantly by 48 h (P = 0.029) and 72 h (P < 0.001). Higher uCl levels at 72 h were associated with CCS ≥ 2 (P for interaction = 0.039), portal vein pulsatility ≥ 30% (P for interaction = 0.018), and ePVS > 5.5 mL/g (P for interaction = 0.035). uNa trajectories differed significantly only across ePVS (P for interaction = 0.015). ROC AUC for predicting residual congestion was slightly higher for uCl (0.819) than uNa (0.790). The optimal cutoff value for uCl to identify residual congestion at 72 h was 61 mmol/L.

conclusionsIn a cohort of elderly patients hospitalized for AHF, persistently elevated urinary chloride at 72 h of admission was associated with residual congestion. Urinary chloride may serve as a promising tool to guide the transition to oral medication once euvolaemia has been achieved.

Indexed as

ChloridesFurosemideHeart FailureSodiumStroke VolumeAcute DiseaseAgedAged, 80 and overBiomarkersDiureticsFemaleFollow-Up StudiesHumansMaleProspective StudiesBiomarkersChloridesDiureticsFurosemideSodiumAcute heart failureCongestionPreserved ejection fractionUrinary chloride

Identifiers

PMID41078081
PMCPMC12719806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.